Abdallah K Alameddine, Frederick T Conlin, Brian J Binnall, Yvonne A Alameddine, Khaled O Alameddine
Journal: Cancer reports (Hoboken, N.J.) 2021;1(1):e1003
PMID: 32729259
BACKGROUND
Multiple genetic changes, availability of cellular nutrients and metabolic alterations play a pivotal role in oncogenesis AIMS: We focus on cancer cell's metabolic properties, and we outline the cross talks between cellular oncogenic growth pathways in cancer metabolism. The review also provides a synopsis of the relevant cancer drugs targeting metabolic activities that are at various stages of clinical development.
METHODS
We review literature published within the last decade to include select articles that have highlighted energy metabolism crucial to the development of cancer phenotypes.
RESULTS
Cancer cells maintain their potent metabolism and keep a balanced redox status by enhancing glycolysis and autophagy and rerouting Krebs cycle intermediates and products of β-oxydation.
CONCLUSIONS
The processes underlying cancer pathogenesis are extremely complex and remain elusive. The new field of systems biology provides a mathematical framework in which these homeostatic dysregulation principles may be examined for better understanding of cancer phenotypes. Knowledge of key players in cancer-related metabolic reprograming may pave the way for new therapeutic metabolism-targeted drugs and ultimately improve patient care.
© 2018 Wiley Periodicals, Inc.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.